ENDPOINTS

Pacira absorbs GQ Bio for $32M; Layoffs at Eisai and CRISPR Therapeutics

Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioSciences takes on GQ Bio: The non-opioid pain biotech is spending $32 million to buy the remaining ...

Feb 28, 2025 - 16:15
 0
Pacira absorbs GQ Bio for $32M; Layoffs at Eisai and CRISPR Therapeutics
Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioSciences takes on GQ Bio: The non-opioid pain biotech is spending $32 million to buy the remaining ...
Read More

Tags:

Previous Article

Hubble Captures New View of Colorful Veil

Next Article

From coral to lab: Understanding biflorane synthase for bioactive compound produ...

Related Posts

GSK follows Pfizer in meningococcal vaccine race with new FDA nod

GSK follows Pfizer in meningococcal vaccine race with n...

Feb 15, 2025  0

What will pharma's share buyback shopping spree mean for M&A?

What will pharma's share buyback shopping spree mean fo...

Feb 11, 2025  0

Pfizer hires former top FDA deputy Patrizia Cavazzoni as CMO

Pfizer hires former top FDA deputy Patrizia Cavazzoni a...

Feb 24, 2025  0